178 related articles for article (PubMed ID: 29641619)
1. Medicalising normality? Using a simulated dataset to assess the performance of different diagnostic criteria of HIV-associated cognitive impairment.
Underwood J; De Francesco D; Leech R; Sabin CA; Winston A;
PLoS One; 2018; 13(4):e0194760. PubMed ID: 29641619
[TBL] [Abstract][Full Text] [Related]
2. Determining optimal impairment rating methodology for a new HIV-associated neurocognitive disorder screening procedure.
Kamminga J; Bloch M; Vincent T; Carberry A; Brew BJ; Cysique LA
J Clin Exp Neuropsychol; 2017 Oct; 39(8):753-767. PubMed ID: 28052738
[TBL] [Abstract][Full Text] [Related]
3. Associations between cognitive impairment and patient-reported measures of physical/mental functioning in older people living with HIV.
Underwood J; De Francesco D; Post FA; Vera JH; Williams I; Boffito M; Mallon PW; Anderson J; Sachikonye M; Sabin C; Winston A;
HIV Med; 2017 May; 18(5):363-369. PubMed ID: 27785907
[TBL] [Abstract][Full Text] [Related]
4. Defining cognitive impairment in people-living-with-HIV: the POPPY study.
De Francesco D; Underwood J; Post FA; Vera JH; Williams I; Boffito M; Sachikonye M; Anderson J; Mallon PW; Winston A; Sabin CA;
BMC Infect Dis; 2016 Oct; 16(1):617. PubMed ID: 27793128
[TBL] [Abstract][Full Text] [Related]
5. Multivariate normative comparison, a novel method for more reliably detecting cognitive impairment in HIV infection.
Su T; Schouten J; Geurtsen GJ; Wit FW; Stolte IG; Prins M; Portegies P; Caan MW; Reiss P; Majoie CB; Schmand BA;
AIDS; 2015 Mar; 29(5):547-57. PubMed ID: 25587908
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of HIV-associated neurocognitive disorder (HAND) in Turkey and assessment of Addenbrooke's Cognitive Examination Revised (ACE-R) test as a screening tool.
Korten V; Ay U; Harı E; Tigen Tükenmez E; Gencer S; Akça Kalem S; Demirtaş Tatlıdede A; Gürvit İH
HIV Med; 2021 Jan; 22(1):60-66. PubMed ID: 32964651
[TBL] [Abstract][Full Text] [Related]
7. Use of Neuroimaging to Inform Optimal Neurocognitive Criteria for Detecting HIV-Associated Brain Abnormalities.
Campbell LM; Fennema-Notestine C; Saloner R; Hussain M; Chen A; Franklin D; Umlauf A; Ellis RJ; Collier AC; Marra CM; Clifford DB; Gelman BB; Sacktor N; Morgello S; McCutchan JA; Letendre S; Grant I; Heaton RK;
J Int Neuropsychol Soc; 2020 Feb; 26(2):147-162. PubMed ID: 31576785
[TBL] [Abstract][Full Text] [Related]
8. Cross-sectional analysis of cognitive function using multivariate normative comparisons in men with HIV disease.
Wang Z; Molsberry SA; Cheng Y; Kingsley L; Levine AJ; Martin E; Munro CA; Ragin A; Rubin LH; Sacktor N; Seaberg EC; Becker JT;
AIDS; 2019 Nov; 33(14):2115-2124. PubMed ID: 31335803
[TBL] [Abstract][Full Text] [Related]
9. Motor function and human immunodeficiency virus-associated cognitive impairment in a highly active antiretroviral therapy-era cohort.
Robinson-Papp J; Byrd D; Mindt MR; Oden NL; Simpson DM; Morgello S;
Arch Neurol; 2008 Aug; 65(8):1096-101. PubMed ID: 18695060
[TBL] [Abstract][Full Text] [Related]
10. HIV associated neurocognitive disorders (HAND) in Malawian adults and effect on adherence to combination anti-retroviral therapy: a cross sectional study.
Kelly CM; van Oosterhout JJ; Ngwalo C; Stewart RC; Benjamin L; Robertson KR; Khoo S; Allain TJ; Solomon T
PLoS One; 2014; 9(6):e98962. PubMed ID: 24915530
[TBL] [Abstract][Full Text] [Related]
11. The HIV Dementia Scale: predictive power in mild dementia and HAART.
Bottiggi KA; Chang JJ; Schmitt FA; Avison MJ; Mootoor Y; Nath A; Berger JR
J Neurol Sci; 2007 Sep; 260(1-2):11-5. PubMed ID: 17482212
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide association study of HIV-associated neurocognitive disorder (HAND): A CHARTER group study.
Jia P; Zhao Z; Hulgan T; Bush WS; Samuels DC; Bloss CS; Heaton RK; Ellis RJ; Schork N; Marra CM; Collier AC; Clifford DB; Gelman BB; Sacktor N; Morgello S; Simpson DM; McCutchan JA; Barnholtz-Sloan JS; Franklin DR; Rosario D; Letendre SL; Grant I; Kallianpur AR;
Am J Med Genet B Neuropsychiatr Genet; 2017 Jun; 174(4):413-426. PubMed ID: 28447399
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the sensitivity, stability, and reliability of three diagnostic schemes for HIV-associated neurocognitive disorders.
Tierney SM; Sheppard DP; Kordovski VM; Faytell MP; Avci G; Woods SP
J Neurovirol; 2017 Jun; 23(3):404-421. PubMed ID: 28108972
[TBL] [Abstract][Full Text] [Related]
14. Predictive validity of demographically adjusted normative standards for the HIV Dementia Scale.
Morgan EE; Woods SP; Scott JC; Childers M; Beck JM; Ellis RJ; Grant I; Heaton RK;
J Clin Exp Neuropsychol; 2008 Jan; 30(1):83-90. PubMed ID: 17852582
[TBL] [Abstract][Full Text] [Related]
15. Defining neurocognitive impairment in HIV: deficit scores versus clinical ratings.
Blackstone K; Moore DJ; Franklin DR; Clifford DB; Collier AC; Marra CM; Gelman BB; McArthur JC; Morgello S; Simpson DM; Ellis RJ; Atkinson JH; Grant I; Heaton RK
Clin Neuropsychol; 2012; 26(6):894-908. PubMed ID: 22708483
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial DNA Haplogroups and Neurocognitive Impairment During HIV Infection.
Hulgan T; Samuels DC; Bush W; Ellis RJ; Letendre SL; Heaton RK; Franklin DR; Straub P; Murdock DG; Clifford DB; Collier AC; Gelman BB; Marra CM; McArthur JC; McCutchan JA; Morgello S; Simpson DM; Grant I; Kallianpur AR;
Clin Infect Dis; 2015 Nov; 61(9):1476-84. PubMed ID: 26129753
[TBL] [Abstract][Full Text] [Related]
17. Preliminary study of a novel cognitive assessment device for the evaluation of HIV-associated neurocognitive impairment.
Anderson AM; Lennox JL; Nguyen ML; Waldrop-Valverde D; Tyor WR; Loring DW
J Neurovirol; 2016 Dec; 22(6):816-822. PubMed ID: 27245594
[TBL] [Abstract][Full Text] [Related]
18. Validation of the International HIV Dementia Scale as a Screening Tool for HIV-Associated Neurocognitive Disorders in a German-Speaking HIV Outpatient Clinic.
Marin-Webb V; Jessen H; Kopp U; Jessen AB; Hahn K
PLoS One; 2016; 11(12):e0168225. PubMed ID: 27992497
[TBL] [Abstract][Full Text] [Related]
19. HIV-associated neurocognitive disorder in Australia: a case of a high-functioning and optimally treated cohort and implications for international neuroHIV research.
Cysique LA; Heaton RK; Kamminga J; Lane T; Gates TM; Moore DM; Hubner E; Carr A; Brew BJ
J Neurovirol; 2014 Jun; 20(3):258-68. PubMed ID: 24696363
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
